|
|
Article: Genetic Engineering and Biotechnology News (GEN) Reports on Mass Spec in Drug Discovery.
- Article from:
- PR Newswire
- Article date:
- May 19, 2008
CopyrightCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW ROCHELLE, N.Y., May 19 /PRNewswire/ -- Mass spectrometry, driven by a broad range of improvements in hardware and software technologies, has given rise to an increasing number of applications in the clinic, according to an article in the May 15 issue of Genetic Engineering and Biotechnology News (GEN) (http://www.genengnews.com/). Mass spec is also playing a greater role in drug discovery due to a growing focus on screening patients through the identification of biomarkers and developing more effective drugs based on structural properties of targets, reports the May 15 issue of GEN (http://www.genengnews.com/articles/chitem.aspx?aid=2469).
"Biomarker ...